Below are frequently-asked questions regarding the UNC REX Pharmacy Residency program:
What distinguishes UNC REX Hospital’s PGY1 Residency from other programs?
The Pharmacy Department at UNC REX serves diverse patient populations within a decentralized pharmacy model. We have an extensive Pharmacy Services presence in the emergency department, multiple oncology pharmacies, ambulatory care clinics, and 4 critical care units. UNC REX is an innovative hospital with an entrepreneurial spirit that is always looking for the best way to provide care for its patients.
What clinical experiences are available?
UNC REX Hospital’s PGY1 Residency offers a variety of robust clinical rotations in both the inpatient and outpatient setting taught by our well-rounded preceptors from diverse practice settings. Take a look at our clinical rotations offered here in the PGY1 Program Design section.
What teaching opportunities are available?
Learn more about our teaching opportunities here in the PGY1 Program Design section.
What research experiences are available?
After the match, residents will be sent a list of potential research projects to pursue. Residents are welcome to pursue their own research project outside of the list as well. Residents are required to reach out to their lead research preceptors in June and July to complete their Research Project Concept Proposals, and create individualized Research Advisory Committees. Interdisciplinary research is highly encouraged. Research projects must be submitted through the Institutional Review Board (IRB) by early September.
What types of research projects have past residents completed?
2019-2020 Residency Class
Brandon Beers, PharmD: Evaluation of efficacy and safety of antithrombotic regimens in patients undergoing Transcatheter Aortic Valve Replacement (TAVR) procedures
Rachel Diaz, PharmD: Evaluation of the use of a pain, agitation, and delirium protocol in the ICU
Ethan Gerrald PharmD: Identification and evaluation of potential patient characteristics that may predispose multiple myeloma patients to develop carfilzomib-induced cardiotoxicities
Steven Skovran, PharmD: Investigation of the ideal antithrombotic regimens for iliac vein thrombosis with stent placement
Olivia Witt, PharmD: Use of investigational assays to validate the use of an institutional heparin nomogram for patients receiving heparin that were previously on oral factor Xa inhibitors
2018-2019 Residency Class
Justin Harrison: Management of heparin anti-Xa lab interference in patients taking direct oral anticoagulants
Becky Nickell: Impact of smoking status on the response rate to pembrolizumab in metastatic non-small cell lung cancer
Justin Wilson: Evaluation of direct oral anticoagulant safety in oncology patients with thrombocytopenia
Olivia Witt: Use of beta-blockers as cardioprotectants for anthracycline chemotherapy
2017-2018 Residency Class
Michael Crawford, PharmD: Evaluating the recurrence rates of seizures in first time seizure patients receiving various antiepileptic medications
Legacy Marsolek, PharmD: Comparison of intravenous n-acetylcysteine dosing strategies in acetaminophen toxicity
Nathan Wayne, PharmD: Safety of uninterrupted vs interrupted anticoagulation around catheter ablation (AF-UNITE)
2016-2017 Residency Class
Rachel LaBianca, PharmD: Impact of dose-capping on time to therapeutic anticoagulation by anti-Xa level for weight-based unfractionated heparin
Zachary Kritzer, PharmD: Evaluation of guideline-discordant empiric vancomycin initiation in oncology patients with febrile neutropenia
J. Alex Toler, PharmD: A retrospective analysis of effectiveness of accelerated dose vs standard dose sotalol initiation in patients with atrial fibrillation or atrial flutter
Elizabeth Weddendorf, PharmD: Assessment of the effect of direct oral anticoagulants for acute treatment of venous thromboembolism in patients with cancer
2015-2016 Residency Class
Tramaine Young, PharmD, MSRC: Methodological study of vancomycin dosing in elderly patients using actual serum creatinine versus rounded serum creatinine
Taylor White, PharmD: Assessment of outcomes in patients with non-valvular atrial fibrillation treated with nonwarfarin oral anticoagulants (NOACS) as dosed in clinical practice
2014- 2015 Residency Class
Will Criswell, PharmD: Evaluation of a Vancomycin Dose-Stacking Protocol in Achieving Initial Goal Trough Concentrations of 15-20 mcg/mL in a Community Hospital
Debbie Liang, PharmD: Major Bleed Risk in Emergency Department (ED) Patients on New Oral Anticoagulants (NOACs) with Concomitant P Glycoprotein (PGP) or Cytochrome P450 (CYP450) Inhibitors
2013- 2014 Residency Class
Madison Dixon (Sasser), PharmD: Subcutaneous Versus Intravenous Patient-Controlled Analgesia in Sickle Cell Pain Crisis
Nastaran Gharkholonarehe, PharmD: Assessing Concomitant Aspirin and Oral Anticoagulation Therapy in Atrial Fibrillation
2012- 2013 Residency Class
Matt Daniel, PharmD: Dose-Range Checking Implementation Within Computerized Physician Order Entry and Medication Order Management Systems at UNC REX Hospital
Tanner Ringley, PharmD: Development of a Risk Stratification System for Prediction of Recurrent Clostridium Difficile Infection (R-CDI)
What are the staffing requirements of the residency?
Residents are required to staff the pharmacy every fourth weekend (8 hour shifts on Saturday and Sunday) and one weekday evening each week in addition to their rotation hours excluding the first two weekends in December to permit attendance at the ASHP Midyear meeting.
Residents will be expected to two holidays as defined from UNC REX policies and procedures.
What are you looking for in a potential candidate?
At UNC REX Hospital, we are looking for well-rounded and motivated potential candidates interested in working in a progressive community hospital. Candidates will need good time management skills, excellent presentation skills, and the ability to work in a self-directed and team-oriented manner.
How are residents selected?
If eligibility requirements are met, potential candidates are required to submit a completed application to UNC REX Hospital by January 1, 2019. UNC REX evaluates potential candidates based on letters of recommendation, letters of intent, prior work, research, and teaching experience, leadership roles, extracurricular activities, and volunteer experience. UNC REX Hospital currently offers four PGY1 resident spots available for 2019.
How are your residents evaluated?
Residents will be formally evaluated by their preceptors through PharmAcademic each month upon completion of each required and elective rotation or quarterly for longitudinal rotations. Preceptors will meet with residents for a final evaluation, and also provide feedback through each rotation. Residents are highly encouraged to provide feedback to preceptors throughout their rotations as well. Typically, residents individually meet with the residency program director biweekly or monthly to evaluate resident progress.
Learn more about Raleigh here. Learn about the cost of living in Raleigh here.